Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon

Regulatory Roundup: FDA approves new heart failure therapy, clears an interventional device and much more

The FDA has been busy this month. Review some of the biggest FDA-related stories of October, including big news from scPharmaceuticals, Abiomed, Bristol Myers Squibb and MedAlliance, in our monthly roundup. 

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Cordis to acquire MedAlliance, known for its drug-eluting balloons, in deal that could surpass $1B

The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

TEER reduces mitral regurgitation, boosts survival among cardiogenic shock patients

Researchers tracked outcomes data and imaging results from nearly 4,000 TEER patients, sharing their findings in the Journal of the American College of Cardiology.

transcarotid TAVR TAVI transcatheter aortic valve replacement

Transcarotid TAVR a safe alternative when femoral access is not an option

The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella heart pumps linked to improved high-risk PCI outcomes

Researchers examined data from patients who underwent high-risk PCI with either an Impella heart pump or an intra-aortic balloon pump.

An updated look at how cognitive impairment affects TAVR outcomes

The connection between cognitive impairment and postoperative delirium among TAVR patients stood out as a definite concern to the study's authors.

cardiologist Peter J. Fitzgerald, MD, PhD, HeartBeam

Cardiac technology startup names cardiologist Peter Fitzgerald its chief medical officer

Fitzgerald, a leading figure in interventional cardiology, praised the company's potential to improve patient outcomes and quality of life. 

A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare

Severe prosthesis-patient mismatch after TAVR linked to a higher risk of death

Researchers examined data from 82,000 TAVR patients, focusing on echocardiography-defined PPM. They shared their results in JACC: Cardiovascular Imaging.

Displaying 513 - 520 of 975
Design by Adaptive Theme